Showing Funds Performance since Sep 07, 2020

| Duration | Fund Return(%) | Category Average(%) | Category Best(%) |
|---|---|---|---|
| 1M | 12.45 | -0.44 | 36.77 |
| 6M | 9.87 | 0.50 | 109.14 |
| 1Y | 19.28 | 3.23 | 237.37 |
| 3Y | 0.00 | 8.94 | 368.51 |
HDFC Pharma and Healthcare Fund Growth managed by HDFC Mutual Fund,is a Equity - Sector Fundscheme with Assets Under Management of ₹1,977 Crore. The fund benchmarks its performance against the BSE Healthcare while maintaining an expense ratio of 2.1. Under the expert guidance of Nikhil Mathur ,the fund implements a disciplined investment approach aligned with its mandate. The scheme requires a minimum investment of ₹500 for SIP and ₹1,000 for lump sum investments, making it accessible to diverse investor profiles.
Mr. Nikhil Mathur holds PGDM - IMT, Ghaziabad, B.E. (Civil) - PEC, Chandigarh, CFA (USA) level 3 cleared. He has over 7 years of experience in equity research and 2 years in financial advisory.
| Fund Name | Ratings | AUM | Expense Ratio |
|---|---|---|---|
| This FundICICI Prudential Quality Fund Growth | 0 | 2011.06 CR | 2.09 |
| This FundAxis Momentum Fund Growth | 0 | 924.27 CR | 2.26 |
| This FundHDFC Pharma and Healthcare Fund Growth | 0 | 1976.86 CR | 2.1 |
| This FundICICI Prudential PSU Equity Fund Growth | 0 | 1798.21 CR | 2.1 |
| This FundNippon India Taiwan Equity Fund Growth | 3 | 599.16 CR | 2.36 |
| Fund Name | 1Y | 3Y |
|---|---|---|
| This FundICICI Prudential Quality Fund Growth | 0 | 0 |
| This FundAxis Momentum Fund Growth | 2.5086 | 0 |
| This FundHDFC Pharma and Healthcare Fund Growth | 19.2766 | 0 |
| This FundICICI Prudential PSU Equity Fund Growth | 15.8964 | 106.3291 |
| This FundNippon India Taiwan Equity Fund Growth | 232.7399 | 349.4066 |